MedTrace Logo

Characterization of Interventricular Conduction Measurements

NCT01362465 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2012-09-20

No results posted yet for this study

Summary

This study is an effort to use left ventricular (LV) lead based measurements to identify late electrical activation and avoid scar.

Conditions

Interventions

PROCEDURE

Cardiac Resynchronization Therapy

Implanting device to measure delays between paced chambers in heart failure patients.

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • Medtronic Cardiac Rhythm and Heart Failure

    lead INDUSTRY

Principal Investigators

  • Brett Atwater, MD · Durham VA

  • Robert Hoyt, MD · Catholic Health Initiative Iowa Corp

  • Eric E Johnson, MD · Sterns Cardiovascular Foundation

  • John F Beshai, MD · University of Chicago

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2012-04-30
Completion
2012-04-30

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01362465 on ClinicalTrials.gov